|
Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 201 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s new report, “Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infe.....
Introduction GlobalData’s new report, “Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Russian Federation In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. - Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017. - 2010 company shares and distribution shares data for each of the seven market categories. - Global corporate-level profiles of key companies operating within the Russian Federation In Vitro Diagnosticsmarket. - Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc. and others. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the Russian Federation In Vitro Diagnostics competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights F. Hoffmann-La Roche Ltd. Siemens Healthcare Abbott Laboratories bioMerieux S.A. Beckman Coulter, Inc. Ortho-Clinical Diagnostics Inc. Bio-Rad Laboratories, Inc. Sysmex Corporation Becton, Dickinson and Company DiaSorin S.p.A Alere Inc. Phadia AB Qiagen N.V. DIAGNOSTICA STAGO, Inc. Danaher Corporation Gen-Probe Incorporated PerkinElmer, Inc. HORIBA, Ltd. Thermo Fisher Scientific Inc. Grifols, S.A. Immucor, Inc. Hologic, Inc. Cellestis Limited Life Technologies Corporation Mindray Medical International Limited [Studien Infos ausblenden] |
|||||||||||
|
1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 9 1.2 List of Figures 12 2 Introduction 15 2.1 What is This Report About? 15 3 In Vitro Diagnostics In Russian Federation 16 3.1 In Vitro Diagnostics, Market Segmentation 16 3.2 In Vitro Diagnostics, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 17 3.3 In Vitro Diagnostics Market, Russian Federation, Revenue Mix ($m), 2010 19 3.4 In Vitro Diagnostics Market, Russian Federation, Category Contribution (%), 2010 20 3.5 In Vitro Diagnostics, Russian Federation, Company share (2009-2010) 27 4 Clinical Chemistry In Russian Federation 29 4.1 Clinical Chemistry, Market Segmentation 29 4.2 Clinical Chemistry Market, Russian Federation, Revenue Mix ($m), 2010 30 4.3 Clinical Chemistry Market, Russian Federation, Segment Contribution (%), 2010 31 4.4 Clinical Chemistry Overall Revenue (2003-2017) 32 4.4.1 Clinical Chemisty Analyzers Revenue (2003-2017) 36 4.4.2 Urine Analysis Revenue (2003-2017) 40 4.5 Clinical Chemistry Distribution Share (2009-2010) 44 4.6 Clinical Chemistry, Russian Federation, Company share (2009-2010) 45 5 Genetic Testing In Russian Federation 47 5.1 Genetic Testing, Market Segmentation 47 5.2 Genetic Testing Market, Russian Federation, Revenue Mix ($m), 2010 48 5.3 Genetic Testing Market, Russian Federation, Segment Contribution (%), 2010 49 5.4 Genetic Testing Overall Revenue (2003-2017) 50 5.5 Genetic Testing Distribution Share (2009-2010) 54 5.6 Genetic Testing, Russian Federation, Company share (2009-2010) 55 6 Haematology In Russian Federation 57 6.1 Haematology, Market Segmentation 57 6.2 Haematology Market, Russian Federation, Revenue Mix ($m), 2010 58 6.3 Haematology Market, Russian Federation, Segment Contribution (%), 2010 59 6.4 Haematology Overall Revenue (2003-2017) 60 6.4.1 Haematology Reagents Revenue (2003-2017) 64 6.4.2 Immunohaematology Revenue (2003-2017) 68 6.4.3 Haemostasis Revenue (2003-2017) 72 6.4.4 Haematology Rapid Tests Revenue (2003-2017) 76 6.4.5 Haematology Cell Counters Revenue (2003-2017) 80 6.5 Haematology Distribution Share (2009-2010) 84 6.6 Haematology, Russian Federation, Company share (2009-2010) 85 7 Histology And Cytology In Russian Federation 87 7.1 Histology And Cytology, Market Segmentation 87 7.2 Histology And Cytology Market, Russian Federation, Revenue Mix ($m), 2010 88 7.3 Histology And Cytology Market, Russian Federation, Segment Contribution (%), 2010 89 7.4 Histology And Cytology Overall Revenue (2003-2017) 90 7.5 Histology And Cytology Distribution Share (2009-2010) 94 7.6 Histology And Cytology, Russian Federation, Company share (2009-2010) 95 8 Immuno Chemistry In Russian Federation 97 8.1 Immuno Chemistry Market, Russian Federation, Revenue Mix ($m), 2010 97 8.2 Immuno Chemistry Market, Russian Federation, Segment Contribution (%), 2010 98 8.3 Immuno Chemistry Overall Revenue (2003-2017) 99 8.3.1 Disease Specific Immunochemistry Revenue (2003-2017) 103 8.3.2 Drugs of Abuse / Toxicology Revenue (2003-2017) 107 8.3.3 Endocrinology Tests Revenue (2003-2017) 111 8.3.4 Therapeutic Drug Monitoring Revenue (2003-2017) 115 8.3.5 Immunochemistry Analyzers Revenue (2003-2017) 119 8.4 Immuno Chemistry Distribution Share (2009-2010) 123 8.5 Immuno Chemistry, Russian Federation, Company share (2009-2010) 124 9 Infectious Immunology In Russian Federation 126 9.1 Infectious Immunology, Market Segmentation 126 9.2 Infectious Immunology Market, Russian Federation, Revenue Mix ($m), 2010 127 9.3 Infectious Immunology Market, Russian Federation, Segment Contribution (%), 2010 128 9.4 Infectious Immunology Overall Revenue (2003-2017) 129 9.5 Infectious Immunology Distribution Share (2009-2010) 133 9.6 Infectious Immunology, Russian Federation, Company share (2009-2010) 134 10 Microbiology Culture In Russian Federation 136 10.1 Microbiology Culture, Market Segmentation 136 10.2 Microbiology Culture Market, Russian Federation, Revenue Mix ($m), 2010 137 10.3 Microbiology Culture Market, Russian Federation, Segment Contribution (%), 2010 138 10.4 Microbiology Culture Overall Revenue (2003-2017) 139 10.4.1 Microbiology Analyzers Revenue (2003-2017) 143 10.5 Microbiology Culture Distribution Share (2009-2010) 147 10.6 Microbiology Culture, Russian Federation, Company share (2009-2010) 148 11 Overview of Key Companies in Russian Federation In Vitro Diagnostics Market 150 11.1 F. Hoffmann-La Roche Ltd. 150 11.1.1 Company Overview 150 11.1.2 Share in the Russian Federation In Vitro Diagnostics Market 150 11.2 Siemens Healthcare 151 11.2.1 Company Overview 151 11.2.2 Share in the Russian Federation In Vitro Diagnostics Market 151 11.3 Abbott Laboratories 152 11.3.1 Company Overview 152 11.3.2 Share in the Russian Federation In Vitro Diagnostics Market 152 11.4 bioMerieux S.A. 153 11.4.1 Company Overview 153 11.4.2 Share in the Russian Federation In Vitro Diagnostics Market 153 11.5 Beckman Coulter, Inc. 154 11.5.1 Company Overview 154 11.5.2 Share in the Russian Federation In Vitro Diagnostics Market 154 11.6 Ortho-Clinical Diagnostics Inc. 155 11.6.1 Company Overview 155 11.6.2 Share in the Russian Federation In Vitro Diagnostics Market 155 11.7 Bio-Rad Laboratories, Inc. 156 11.7.1 Company Overview 156 11.8 Sysmex Corporation 156 11.8.1 Company Overview 156 11.9 Becton, Dickinson and Company 156 11.9.1 Company Overview 156 11.10 DiaSorin S.p.A 157 11.10.1 Company Overview 157 11.11 Alere Inc. 157 11.11.1 Company Overview 157 11.12 Phadia AB 157 11.12.1 Company Overview 157 11.13 Qiagen N.V. 158 11.13.1 Company Overview 158 11.14 DIAGNOSTICA STAGO, Inc. 158 11.14.1 Company Overview 158 11.15 Danaher Corporation 158 11.15.1 Company Overview 158 11.16 Gen-Probe Incorporated 159 11.16.1 Company Overview 159 11.17 PerkinElmer, Inc. 159 11.17.1 Company Overview 159 11.18 HORIBA, Ltd. 159 11.18.1 Company Overview 159 11.19 Thermo Fisher Scientific Inc. 160 11.19.1 Company Overview 160 11.20 Grifols, S.A. 160 11.20.1 Company Overview 160 11.21 Immucor, Inc. 161 11.21.1 Company Overview 161 11.22 Hologic, Inc. 161 11.22.1 Company Overview 161 11.23 Cellestis Limited 162 11.23.1 Company Overview 162 11.24 Life Technologies Corporation 162 11.24.1 Company Overview 162 11.25 Mindray Medical International Limited 163 11.25.1 Company Overview 163 12 In Vitro Diagnostics Market Pipeline Products 164 12.1 Clinical Chemisty Market Pipeline Products 164 12.2 Immuno Chemistry Market Pipeline Products 167 12.3 Haematology Market Pipeline Products 170 12.4 Infectious Immunology Market Pipeline Products 172 12.5 Microbiology Culture Market Pipeline Products 175 12.6 Histology And Cytology Market Pipeline Products 176 12.7 Genetic Testing Market Pipeline Products 177 13 Financial Deals Landscape 180 13.1 Partnerships 180 13.1.1 Enigma Diagnostics Enters Into Co-Development Agreement with GlaxoSmithKline 180 13.1.2 Biofortuna Enters Into Distribution Agreement with Abbott 181 13.1.3 Trinity Biotech Enters Into Distribution Agreement with A. Menarini Diagnostics 182 13.1.4 Neuro-Biotech Enters Into Licensing Agreement with Credo-TM 183 14 Recent Developments 184 14.1 Strategy and Business Planning 184 14.1.1 Jun 16, 2011: Novartis Begins Construction of New Pharmaceutical Manufacturing Plant in St. Petersburg, Russia 184 14.2 Government and Public Interest 185 14.2.1 Feb 07, 2011: NEARMEDIC Production of Diagnostic Reagent Kits Passed International Certification 185 15 Appendix 186 15.1 Definitions of Markets Covered in the Report 187 15.1.1 In Vitro Diagnostics 187 15.2 Research Methodology 198 15.3 Secondary Research 198 15.4 Primary Research 199 15.5 Models 199 15.6 Forecasts 200 15.7 Expert Panels 200 15.8 GlobalData Consulting 200 15.9 Currency Conversion 201 15.10 Contact Us 201 15.11 Disclaimer 201 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
1.1 List of Tables Table 1: In Vitro Diagnostics, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 18 Table 2: In Vitro Diagnostics Market, Russian Federation, Category Contribution (%), 2010 20 Table 3: In Vitro Diagnostics, Russian Federation, Cross-Category Analysis, 2003-2017 22 Table 4: In Vitro Diagnostics, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24 Table 5: In Vitro Diagnostics, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26 Table 6: In Vitro Diagnostics, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 28 Table 7: Clinical Chemistry Market, Russian Federation, Segment Contribution (%), 2010 31 Table 8: Clinical Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 33 Table 9: Clinical Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 35 Table 10: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 37 Table 11: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 39 Table 12: Urine Analysis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 41 Table 13: Urine Analysis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 43 Table 14: Clinical Chemistry, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44 Table 15: Clinical Chemistry, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 46 Table 16: Genetic Testing Market, Russian Federation, Segment Contribution (%), 2010 49 Table 17: Genetic Testing, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 51 Table 18: Genetic Testing, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 53 Table 19: Genetic Testing, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 54 Table 20: Genetic Testing, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 56 Table 21: Haematology Market, Russian Federation, Segment Contribution (%), 2010 59 Table 22: Haematology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 61 Table 23: Haematology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 63 Table 24: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 65 Table 25: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 67 Table 26: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 69 Table 27: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 71 Table 28: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 73 Table 29: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 75 Table 30: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 77 Table 31: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 79 Table 32: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 81 Table 33: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 83 Table 34: Haematology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 84 Table 35: Haematology, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 86 Table 36: Histology And Cytology Market, Russian Federation, Segment Contribution (%), 2010 89 Table 37: Histology And Cytology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 91 Table 38: Histology And Cytology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 93 Table 39: Histology And Cytology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 94 Table 40: Histology And Cytology, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 96 Table 41: Immuno Chemistry Market, Russian Federation, Segment Contribution (%), 2010 98 Table 42: Immuno Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 100 Table 43: Immuno Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 102 Table 44: Disease Specific Immunochemistry, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 104 Table 45: Disease Specific Immunochemistry, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 106 Table 46: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 108 Table 47: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 110 Table 48: Endocrinology Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 112 Table 49: Endocrinology Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 114 Table 50: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 116 Table 51: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 118 Table 52: Immunochemistry Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 120 Table 53: Immunochemistry Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 122 Table 54: Immuno Chemistry, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 123 Table 55: Immuno Chemistry, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 125 Table 56: Infectious Immunology Market, Russian Federation, Segment Contribution (%), 2010 128 Table 57: Infectious Immunology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 130 Table 58: Infectious Immunology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 132 Table 59: Infectious Immunology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 133 Table 60: Infectious Immunology, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 135 Table 61: Microbiology Culture Market, Russian Federation, Segment Contribution (%), 2010 138 Table 62: Microbiology Culture, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 140 Table 63: Microbiology Culture, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 142 Table 64: Microbiology Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 144 Table 65: Microbiology Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 146 Table 66: Microbiology Culture, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 147 Table 67: Microbiology Culture, Russian Federation, Company share by Revenue ($m), USD Actual 2009-2010 149 Table 68: Clinical Chemisty Market Pipeline Products 164 Table 69: Immuno Chemistry Market Pipeline Products 167 Table 70: Haematology Market Pipeline Products 170 Table 71: Infectious Immunology Market Pipeline Products 172 Table 72: Microbiology Culture Market Pipeline Products 175 Table 73: Histology And Cytology Market Pipeline Products 176 Table 74: Genetic Testing Market Pipeline Products 177 Table 75: Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 180 Table 76: Biofortuna Enters Into Distribution Agreement With Abbott 181 Table 77: Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 182 Table 78: Neuro-Biotech Enters Into Licensing Agreement With Credo-TM 183 Table 79: USD to Local Currency, Russian Federation, Average Actual Rate 2003-2010 201 1.2 List of Figures Figure 1: In Vitro Diagnostics, Market Segmentation 16 Figure 2: In Vitro Diagnostics, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 17 Figure 3: In Vitro Diagnostics Market, Russian Federation, Revenue Mix ($m), 2010 19 Figure 4: In Vitro Diagnostics Market, Russian Federation, Category Contribution (%), 2010 20 Figure 5: In Vitro Diagnostics, Russian Federation, Cross-Category Analysis, 2003-2017 21 Figure 6: In Vitro Diagnostics, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 23 Figure 7: In Vitro Diagnostics, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 25 Figure 8: In Vitro Diagnostics, Russian Federation, Company share (%), 2010 27 Figure 9: Clinical Chemistry, Market Segmentation 29 Figure 10: Clinical Chemistry Market, Russian Federation, Revenue Mix ($m), 2010 30 Figure 11: Clinical Chemistry Market, Russian Federation, Segment Contribution (%), 2010 31 Figure 12: Clinical Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 32 Figure 13: Clinical Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 34 Figure 14: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 36 Figure 15: Clinical Chemisty Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 38 Figure 16: Urine Analysis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 40 Figure 17: Urine Analysis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 42 Figure 18: Clinical Chemistry, Russian Federation, Company share (%), 2010 45 Figure 19: Genetic Testing, Market Segmentation 47 Figure 20: Genetic Testing Market, Russian Federation, Revenue Mix ($m), 2010 48 Figure 21: Genetic Testing Market, Russian Federation, Segment Contribution (%), 2010 49 Figure 22: Genetic Testing, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 50 Figure 23: Genetic Testing, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 52 Figure 24: Genetic Testing, Russian Federation, Company share (%), 2010 55 Figure 25: Haematology, Market Segmentation 57 Figure 26: Haematology Market, Russian Federation, Revenue Mix ($m), 2010 58 Figure 27: Haematology Market, Russian Federation, Segment Contribution (%), 2010 59 Figure 28: Haematology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 60 Figure 29: Haematology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 62 Figure 30: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 64 Figure 31: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 66 Figure 32: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 68 Figure 33: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 70 Figure 34: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 72 Figure 35: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 74 Figure 36: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 76 Figure 37: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 78 Figure 38: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 80 Figure 39: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 82 Figure 40: Haematology, Russian Federation, Company share (%), 2010 85 Figure 41: Histology And Cytology, Market Segmentation 87 Figure 42: Histology And Cytology Market, Russian Federation, Revenue Mix ($m), 2010 88 Figure 43: Histology And Cytology Market, Russian Federation, Segment Contribution (%), 2010 89 Figure 44: Histology And Cytology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 90 Figure 45: Histology And Cytology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 92 Figure 46: Histology And Cytology, Russian Federation, Company share (%), 2010 95 Figure 47: Immuno Chemistry Market, Russian Federation, Revenue Mix ($m), 2010 97 Figure 48: Immuno Chemistry Market, Russian Federation, Segment Contribution (%), 2010 98 Figure 49: Immuno Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 99 Figure 50: Immuno Chemistry, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 101 Figure 51: Disease Specific Immunochemistry, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 103 Figure 52: Disease Specific Immunochemistry, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 105 Figure 53: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 107 Figure 54: Drugs of Abuse / Toxicology, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 109 Figure 55: Endocrinology Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 111 Figure 56: Endocrinology Tests, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 113 Figure 57: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 115 Figure 58: Therapeutic Drug Monitoring, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 117 Figure 59: Immunochemistry Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 119 Figure 60: Immunochemistry Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 121 Figure 61: Immuno Chemistry, Russian Federation, Company share (%), 2010 124 Figure 62: Infectious Immunology, Market Segmentation 126 Figure 63: Infectious Immunology Market, Russian Federation, Revenue Mix ($m), 2010 127 Figure 64: Infectious Immunology Market, Russian Federation, Segment Contribution (%), 2010 128 Figure 65: Infectious Immunology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 129 Figure 66: Infectious Immunology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 131 Figure 67: Infectious Immunology, Russian Federation, Company share (%), 2010 134 Figure 68: Microbiology Culture, Market Segmentation 136 Figure 69: Microbiology Culture Market, Russian Federation, Revenue Mix ($m), 2010 137 Figure 70: Microbiology Culture Market, Russian Federation, Segment Contribution (%), 2010 138 Figure 71: Microbiology Culture, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 139 Figure 72: Microbiology Culture, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 141 Figure 73: Microbiology Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 143 Figure 74: Microbiology Analyzers, Russian Federation, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 145 Figure 75: Microbiology Culture, Russian Federation, Company share (%), 2010 148 Figure 76: F. Hoffmann-La Roche Ltd., Company Share (%),Russian Federation In Vitro Diagnostics Market, 2010 150 Figure 77: Siemens Healthcare, Company Share (%),Russian Federation In Vitro Diagnostics Market, 2010 151 Figure 78: Abbott Laboratories, Company Share (%),Russian Federation In Vitro Diagnostics Market, 2010 152 Figure 79: bioMerieux S.A., Company Share (%),Russian Federation In Vitro Diagnostics Market, 2010 153 Figure 80: Beckman Coulter, Inc., Company Share (%),Russian Federation In Vitro Diagnostics Market, 2010 154 Figure 81: Ortho-Clinical Diagnostics Inc., Company Share (%),Russian Federation In Vitro Diagnostics Market, 2010 155 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
